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affectsurvivalfor all patientsor for any subgroup(p = 0.4). Independent
predictorsof reoperationwereyoungerage, CE prosthesis,and previous
medianstemotomy.In patientsover65 yearsold, choiceof prosthesisdid
not affectactual freedomfrom reoperation(99 + 1/97 * 1/95 + 2Y0 for
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of allogrsftvasculopathy.In this study,the prognosticvalueof DSE(5-
40 @@rein; assessmentof wall motionabnormalities(WMA)usinga 16
segmentmodel)wasanalyzedin S3patients(P,meanage50 A 10years)
late(?12, mean47 + 32 months)t$terhearttransplantation(HTX).Cardiac
events(myocerdiainfarction,needfor revascularization,heartfailure,re-
HTX, death) were registeredduringfollow-up.DSEwas also compared
with imonary angiographyand intravascularultrasound(IVUS,grades1-
6). Results: 167DSE,144angiogramsand 87 IVUSwereperformed(l-4
studiee/P).Withinan obsemationperiodof 1602patientmonths,15events
occurredin 10 P: revascularization,n = 9; re-HTX,n = 2; heartfailure,n
= 2; death,n = 2.14 of SOabnormalDSEand 1 of 87 normalDSEwere
followedby an event.AbnormalDSEstudiesfollowadbyan event(n = 14)
showadWMAin moresegments(7.3+ 4.2 vs.5.0 + 3.1, p < 0.05)anda
higherwallmotionscoreindex(1.52+ 0.30vs. 1.34+ 0.26,p c 0.05)than
abnormalDSEwithoutevent.Newlydevelop6dWMAoran increaseinWMA
scoreindexwere indicators of events in sertal studies.13 of 53 abnormal
angiogramsand 2 of 93 normalengiogramswerefollowedby an event.In
P with noor mild intimalhyparplasiaby IVUS(meanIVUSgrade< 3.0;26
of 87 studies),noeventoccurred.Conclusions: NoninvaeiveDSEmayadd
relevantprognosticinformationin P lateafter HTX.In P with normalDSE,
probabilityof clinicaleventsis low.The prognosticvalueof a normalDSE
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UPtime of 48 + 6 (SD) months,were studied.All patientsexcept3 had
coronay angiography1 dayafterthe dobutaminestresstest. Medications
at thetimeof thetest includedcalciumantagonists(n= 19),ACEinhibitors
(n = 13), and beta blockers(n = 4). The meanbaselineand peak heart




conclusion,this studyis uniquefor 2 reasons:first, it is the first to assess
the comparativevalueof both dobutamineTI-201SPECTand DSEdone
concomitantlyin cenliactransplantrecipients:second,on the basisof our
results,dobutaminestresstestingis well toleratedand meritsconsidera-
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Regionalwall motionabnormalities(RWMA)demonstratedby dobutamine
















WMSI CFR (n = 14) p-Value
1,0 2.5 + 003 NS
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Background: Atherosclerosisis a majorcomplicationof hearttrensplante-
tion. A highplasmahomccysteine(HCY)concentrationis a riskfactorfor
atherosclerosisand maybe causedby lowfolate,vitaminB12or S6 levels
andrenalfailure.
Aims and Methods:To detectabnormalitiesof homocysteinemateboliem




Results: Homocysteinelevelswerehigherin recipients(16.5+ 8.6vs 11
+ 3.6&mol/L,p < 0.001)aswasserumcreatinine(1.65+ 1.6vs0.97+ 0.2
mg/dl,p c 0.001).A highhomocysteine(=-90 th percentilefor controle,14
&mol/L)wasseenin66 recipients(62Yo)comparedto 11controls(1OYO,p <
0.01).Homocysteinecorrelatednegativelywithfolate(r = -0.46, p < 0.01)
andvitaminB12(r= -0.23, p c 0.01)andpositivelywithcreatinine(r=0.19,
p= 0.08).
HCY B12 deficiency Folate deficiency 66 dsficiencv
pmol/L <125 pmoVL- <5.2 nmoVL <20 nrnoVL-
Controls 11.03 + 3.83 5 (4.80/n) 2 (1.9%)
Recipients
3 (2.9%)
16.52 + 8.64* 4 (4”/0) 20(20%)* 19 (20%)”
*p< 0.001
Concksions: A highplasmahomocysteineconcentrationisoftenseenin
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Thedevelopmentof graft coronaryarterydisease(g-CAD)hasbecomean
